Autumn is gradually deepening, and the journey begins again. On September 17, 2025, the "New Quality Engine · Intelligent Leadership for the Future" national tour of master's and doctoral students, sponsored by Gaobo Talent, was successfully held at East China University of Science and Technology and Fudan University. Shanghai Lishan Biopharmaceutical Co., Ltd., as one of the participating companies, discussed the cutting-edge trends and career development prospects of biopharmaceuticals with numerous young talents with dreams in mind. The lively communication and in-depth interaction at the event site injected vigorous innovation vitality into this golden autumn.   Live coverage： East China University of Science and Technology Special Session (9:00-12:00 AM) Location: Yifu Building Lecture Hall, Xuhui Campus, East China University...

Dear classmates, have you noticed the recent wave of transfer in the field of innovative drugs in China, and are you holding ideals and preparing to take action? Do you aspire to stand at the forefront of biopharmaceutical technology and drive world change with the power of innovation? Are you looking forward to joining a team driven by artificial intelligence and big data, dedicated to tackling major health challenges for humanity? Shanghai Lishan Biopharmaceutical Co., Ltd.'s 2025 campus recruitment has officially started! We are looking for you who dare to dream and take action, to join us in writing new legends in the vast ocean of life sciences.   About Lishan Lishan Biotech relies on its profound scientific research accumulation and industrialization experience, driven by artificial intelligence and big data, to build a golden triangle system of "efficient discov...

  On June 19, 2025, at the headquarters building of Douzheng Biotechnology in Changsha, Lishan Biotech and leading domestic CRO enterprise Douzheng Biotechnology officially reached a strategic cooperation to jointly promote the clinical trials of Lishan Biotech's independently developed live biopharmaceutical (LBP) in the field of inflammatory bowel disease (IBD). This cooperation marks a new stage in the clinical exploration of live biopharmaceutical therapy, which is expected to provide safer and more effective innovative therapies for IBD patients worldwide.   Innovative treatment for IBD using LBP biopharmaceuticals Live Biotherapeutic Products (LBP) is an emerging therapy that utilizes live microorganisms to regulate the human microbiota for the treatment of diseases, and is considered the "third generation therapy" after small molecule...

On the morning of May 15, 2025, the Zhangjiang China Medicine Valley Conference Room welcomed a team of evaluation experts led by the Pudong New Area Science and Technology Commission to assess the digital transformation achievements of Shanghai Lishan Biopharmaceutical Co., Ltd. on site. Dr. Zhu Chaoyu, General Manager of Lishan Biotechnology, along with Ms. Guo Yushan, Manager of the Research Project Management Department, Dr. Wang Mengya, Deputy Director of Zhangjiang Live Biopharmaceutical R&D Center, Ms. Song Junmei, Deputy General Manager, Mr. Yang Weikang, Manager of the Production Quality Department, and other team members, participated in the on-site review, which was chaired and reported by Ms. Guo Yushan. Starting from September 1, 2024, Lishan Biotechnology has completed the upgrade and deployment of the Su...